Literature DB >> 22634083

In-depth analysis of the human tear proteome.

Lei Zhou1, Shao Zhen Zhao, Siew Kwan Koh, Liyan Chen, Candida Vaz, Vivek Tanavde, Xiao Rong Li, Roger W Beuerman.   

Abstract

The tears, a critical body fluid of the surface of the eye, contain an unknown number of molecules including proteins/peptides, lipids, small molecule metabolites, and electrolytes. There have been continued efforts for exploring the human tear proteome to develop biomarkers of disease. In this study, we used the high speed TripleTOF 5600 system as the platform to analyze the human tear proteome from healthy subjects (3 females and 1 male, average age: 36±14). We have identified 1543 proteins in the tears with less than 1% false discovery rate, which represents the largest number of human tear proteins reported to date. The data set was analyzed for gene ontology (GO) and compared with the human plasma proteome, NEIBank lacrimal gland gene dataset and NEIBank cornea gene dataset. This comprehensive tear protein list may serve as a reference list of human tear proteome for biomarker research of ocular diseases or establishment of MRM (Multiple Reaction Monitoring) assays for targeted analysis. Tear fluid is a useful and an accessible source not only for evaluating ocular surface tissues (cornea and conjunctiva), inflammation, lacrimal gland function and a number of disease conditions, such as dry eye as well as response to treatment.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634083     DOI: 10.1016/j.jprot.2012.04.053

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  90 in total

1.  New perspectives in human tear analysis?

Authors:  Peter Kukumberg; Martin Karlík; Denisa Beňová-Liszeková; Milan Beño; Tibor Pechan; Robert Farkaš
Journal:  Neuro Endocrinol Lett       Date:  2015       Impact factor: 0.765

Review 2.  Wearable biosensors for healthcare monitoring.

Authors:  Jayoung Kim; Alan S Campbell; Berta Esteban-Fernández de Ávila; Joseph Wang
Journal:  Nat Biotechnol       Date:  2019-02-25       Impact factor: 54.908

Review 3.  Lacritin and the tear proteome as natural replacement therapy for dry eye.

Authors:  Roy Karnati; Diane E Laurie; Gordon W Laurie
Journal:  Exp Eye Res       Date:  2013-06-12       Impact factor: 3.467

4.  Extensive characterization of human tear fluid collected using different techniques unravels the presence of novel lipid amphiphiles.

Authors:  Sin Man Lam; Louis Tong; Xinrui Duan; Andrea Petznick; Markus R Wenk; Guanghou Shui
Journal:  J Lipid Res       Date:  2013-11-28       Impact factor: 5.922

Review 5.  TFOS DEWS II Tear Film Report.

Authors:  Mark D P Willcox; Pablo Argüeso; Georgi A Georgiev; Juha M Holopainen; Gordon W Laurie; Tom J Millar; Eric B Papas; Jannick P Rolland; Tannin A Schmidt; Ulrike Stahl; Tatiana Suarez; Lakshman N Subbaraman; Omür Ö Uçakhan; Lyndon Jones
Journal:  Ocul Surf       Date:  2017-07-20       Impact factor: 5.033

6.  Ocular surface extracellular DNA and nuclease activity imbalance: a new paradigm for inflammation in dry eye disease.

Authors:  Snehal Sonawane; Vishakha Khanolkar; Abed Namavari; Shweta Chaudhary; Sonal Gandhi; Sapna Tibrewal; Sarmad H Jassim; Brittany Shaheen; Joelle Hallak; John H Horner; Martin Newcomb; Joy Sarkar; Sandeep Jain
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-17       Impact factor: 4.799

7.  New testing options for diagnosing and grading dry eye disease.

Authors:  Gary N Foulks; Stephen C Pflugfelder
Journal:  Am J Ophthalmol       Date:  2014-03-12       Impact factor: 5.258

8.  Clusterin from human clinical tear samples: Positive correlation between tear concentration and Schirmer strip test results.

Authors:  Valerie Yu; Dhruva Bhattacharya; Andrew Webster; Aditi Bauskar; Charles Flowers; Martin Heur; Shravan K Chintala; Tatsuo Itakura; Mark R Wilson; Joseph T Barr; Shinwu Jeong; Mingwu Wang; M Elizabeth Fini
Journal:  Ocul Surf       Date:  2018-08-02       Impact factor: 5.033

9.  Tissue transglutaminase is a negative regulator of monomeric lacritin bioactivity.

Authors:  Francisco Velez V; Jeffrey A Romano; Robert L McKown; Kari Green; Liwen Zhang; Ronald W Raab; Denise S Ryan; Cindy M L Hutnik; Henry F Frierson; Gordon W Laurie
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-01       Impact factor: 4.799

10.  Analysis of the effects of preservative-free tafluprost on the tear proteome.

Authors:  Sebastian Funke; Sabine Beck; Katrin Lorenz; Marion Kotterer; Dominik Wolters; Natarajan Perumal; Norbert Pfeiffer; Franz H Grus
Journal:  Am J Transl Res       Date:  2016-10-15       Impact factor: 4.060

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.